Literature DB >> 21214312

Adequacy of herniated disc tissue as a cell source for nucleus pulposus regeneration.

Aldemar A Hegewald1, Michaela Endres, Alexander Abbushi, Mario Cabraja, Christian Woiciechowsky, Kirsten Schmieder, Christian Kaps, Claudius Thomé.   

Abstract

OBJECT: The object of this study was to characterize the regenerative potential of cells isolated from herniated disc tissue obtained during microdiscectomy. The acquired data could help to evaluate the feasibility of these cells for autologous disc cell transplantation.
METHODS: From each of 5 patients (mean age 45 years), tissue from the nucleus pulposus compartment as well as from herniated disc was obtained separately during microdiscectomy of symptomatic herniated lumbar discs. Cells were isolated, and in vitro cell expansion for cells from herniated disc tissue was accomplished using human serum and fibroblast growth factor-2. For 3D culture, expanded cells were loaded in a fibrin-hyaluronan solution on polyglycolic acid scaffolds for 2 weeks. The formation of disc tissue was documented by histological staining of the extracellular matrix as well as by gene expression analysis of typical disc marker genes.
RESULTS: Cells isolated from herniated disc tissue showed significant signs of dedifferentiation and degeneration in comparison with cells from tissue of the nucleus compartment. With in vitro cell expansion, further dedifferentiation with distinct suppression of major matrix molecules, such as aggrecan and Type II collagen, was observed. Unlike in previous reports of cells from the nucleus compartment, the cells from herniated disc tissue showed only a weak redifferentiation process in 3D culture. However, propidium iodide/fluorescein diacetate staining documented that 3D assembly of these cells in polyglycolic acid scaffolds allows prolonged culture and high viability.
CONCLUSIONS: Study results suggested a very limited regenerative potential for cells harvested from herniated disc tissue. Further research on 2 major aspects in patient selection is suggested before conducting reasonable clinical trials in this matter: 1) diagnostic strategies to predict the regenerative potential of harvested cells at a radiological or cell biology level, and 2) clinical assessment strategies to elucidate the metabolic state of the targeted disc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214312     DOI: 10.3171/2010.10.SPINE10223

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  14 in total

Review 1.  Reconstruction of an in vitro niche for the transition from intervertebral disc development to nucleus pulposus regeneration.

Authors:  Mark Shoukry; Jingting Li; Ming Pei
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

Review 2.  The role of stem cell therapies in degenerative lumbar spine disease: a review.

Authors:  David Oehme; Tony Goldschlager; Jeffrey V Rosenfeld; Peter Ghosh; Graham Jenkin
Journal:  Neurosurg Rev       Date:  2015-03-07       Impact factor: 3.042

3.  Establishing a through-puncture model for assessing post-injection leakage in the intervertebral disc.

Authors:  Lara J Varden; Evan J Turner; Allison T Coon; Arthur J Michalek
Journal:  Eur Spine J       Date:  2022-02-18       Impact factor: 3.134

4.  Impact of Wnt signals on human intervertebral disc cell regeneration.

Authors:  Tyler Pizzute; Fan He; Xiao-Bing Zhang; Ming Pei
Journal:  J Orthop Res       Date:  2018-08-06       Impact factor: 3.494

Review 5.  Biologic treatment of mild and moderate intervertebral disc degeneration.

Authors:  Elias S Vasiliadis; Spyros G Pneumaticos; Demitrios S Evangelopoulos; Athanasios G Papavassiliou
Journal:  Mol Med       Date:  2014-09-18       Impact factor: 6.354

6.  Nucleus pulposus degeneration alters properties of resident progenitor cells.

Authors:  Olga Mizrahi; Dmitriy Sheyn; Wafa Tawackoli; Shiran Ben-David; Susan Su; Ning Li; Anthony Oh; Hyun Bae; Dan Gazit; Zulma Gazit
Journal:  Spine J       Date:  2013-04-09       Impact factor: 4.166

Review 7.  Mesenchymal stem cells: potential application in intervertebral disc regeneration.

Authors:  Aiqun Wei; Bojiang Shen; Lisa Williams; Ashish Diwan
Journal:  Transl Pediatr       Date:  2014-04

Review 8.  Cell-Based Therapies Used to Treat Lumbar Degenerative Disc Disease: A Systematic Review of Animal Studies and Human Clinical Trials.

Authors:  David Oehme; Tony Goldschlager; Peter Ghosh; Jeffrey V Rosenfeld; Graham Jenkin
Journal:  Stem Cells Int       Date:  2015-05-14       Impact factor: 5.443

9.  Regenerative and immunogenic characteristics of cultured nucleus pulposus cells from human cervical intervertebral discs.

Authors:  Stefan Stich; Meaghan Stolk; Pierre Pascal Girod; Claudius Thomé; Michael Sittinger; Jochen Ringe; Martina Seifert; Aldemar Andres Hegewald
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

10.  Viability, growth kinetics and stem cell markers of single and clustered cells in human intervertebral discs: implications for regenerative therapies.

Authors:  Sarah Turner; Birender Balain; Bruce Caterson; Clare Morgan; Sally Roberts
Journal:  Eur Spine J       Date:  2014-08-06       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.